Nu Skin Enterprises Inc has had a tumultuous few years. It achieved substantial sales growth in the highly coveted Chinese beauty market, only for its success to come tumbling down after investigations into its Chinese business forced a temporary stop to sales. Rebuilding in China will be a priority. It is also seeking to develop a stronger position as a premium anti-ageing specialist, and is seeking to develop a more completely science-led position for its ageLOC brand.
Euromonitor International’s Nu Skin Enterprises Inc in Beauty and Personal Care (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in Beauty and Personal Care industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Product coverage: Baby and Child-specific Products, Bath and Shower, Colour Cosmetics, Deodorants, Depilatories, Fragrances, Hair Care, Mass Beauty and Personal Care, Men’s Grooming, Oral Care, Oral Care Excl Power Toothbrushes, Premium Beauty and Personal Care, Sets/Kits, Skin Care, Sun Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Beauty and Personal Care market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Our reports have been used by over 10K customers, including:
48 pages •
By Euromonitor International
• Jul 2017
Amway Corp saw a sharp decline in beauty and personal care sales over 2011-2016. Its main problem is plummeting sales in China, its largest market, as it has come under threat from other direct sellers, local competitors and weakening demand for its offer and sales model. Although Amway appears to be sanguine about this, it needs a sharp overhaul...